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Abstract 
Background: Current standard interventions are not universally sufficient for malaria elimination. The effects of 
community‑based house improvement (HI) and larval source management (LSM) as supplementary interventions to 
the Malawi National Malaria Control Programme (NMCP) interventions were assessed in the context of an intensive 
community engagement programme.
Methods: The study was a two‑by‑two factorial, cluster‑randomized controlled trial in Malawi. Village clusters were 
randomly assigned to four arms: a control arm; HI; LSM; and HI + LSM. Malawi NMCP interventions and community 
engagement were used in all arms. Household‑level, cross‑sectional surveys were conducted on a rolling, 2‑monthly 
basis to measure parasitological and entomological outcomes over 3 years, beginning with one baseline year. The 
primary outcome was the entomological inoculation rate (EIR). Secondary outcomes included mosquito density, 
Plasmodium falciparum prevalence, and haemoglobin levels. All outcomes were assessed based on intention to treat, 
and comparisons between trial arms were conducted at both cluster and household level.
Results: Eighteen clusters derived from 53 villages with 4558 households and 20,013 people were randomly 
assigned to the four trial arms. The mean nightly EIR fell from 0.010 infectious bites per person (95% CI 0.006–0.015) 
in the baseline year to 0.001 (0.000, 0.003) in the last year of the trial. Over the full trial period, the EIR did not differ 
between the four trial arms (p = 0.33). Similar results were observed for the other outcomes: mosquito density and P. 
falciparum prevalence decreased over 3 years of sampling, while haemoglobin levels increased; and there were mini‑
mal differences between the trial arms during the trial period.
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Background
The global burden of malaria was dramatically reduced 
from 2000 to 2015 [1]. In Africa, where 92% of malaria 
cases occur, this reduction was largely attributed to 
vector control with insecticide-treated bed nets (ITNs) 
and indoor residual spraying (IRS), and treatment with 
artemisinin-based combination therapy [2]. Yet pro-
gress in malaria control stalled in the period 2015–
2017, with an estimated 219 million malaria cases 
occurring worldwide annually [3]. There are multiple, 
overlapping challenges limiting the ability of the cur-
rent malaria interventions to continue reducing malaria 
burden at the rate observed from 2000 to 2015, includ-
ing insecticide resistance [4], drug resistance [5], bar-
riers to achieving target access, use, acceptability and 
sustainability [6], and residual malaria transmission [7].
Due to these well documented challenges, the need 
for additional malaria interventions is widely recog-
nized [8]. In most cases, it is envisaged that additional 
interventions need to be deployed alongside existing 
core interventions, potentially leading to additive or 
synergistic effects beyond that of the core interventions 
on their own. Two vector control interventions that 
could provide additional protection from malaria when 
integrated into standard national control programmes 
are house improvement (HI) and larval source manage-
ment (LSM) [9].
HI includes any structural modifications that reduce 
or eliminate mosquito house entry, such as plastering or 
screening walls, ceilings, eaves, windows or doors. The 
modifications may include a chemical component that 
repels or kills mosquitoes, such as eave baffles or eave 
tubes [10, 11], but they can also be entirely mechani-
cal barriers. LSM includes any changes to water bodies 
that are potential larval habitats of mosquitoes to pre-
vent the completion of development of the immature 
stages [12]. In recent decades, larval source manage-
ment has most commonly consisted of either applying 
larvicides to potential larval habitats, or permanently 
removing the water bodies through draining or filling.
HI and LSM have both been associated with reducing 
malaria transmission in a wide variety of settings histori-
cally [12, 13]. More recently, improved housing resulting 
from more favourable social and economic conditions 
(in this case defined as houses built using finished wall, 
roof, and floor materials [14]) was associated with lower 
malaria parasite infection rates across the full range of 
malaria endemicity in Africa [14]. Two controlled trials of 
house improvement reporting epidemiological outcomes 
have been conducted in Africa [15, 16]. In both trials, the 
interventions were randomized at the household level, 
and house improvement reduced the number of Anophe-
les mosquitoes indoors. HI reduced the risk of anaemia in 
children in The Gambia [15] and the incidence of malaria 
cases in children in Ethiopia [16]. Results of recent con-
trolled trials of LSM on epidemiological outcomes in 
Africa have been mixed, suggesting that the impact is 
dependent on both the larval ecology of the local vector 
mosquitoes and the implementation strategy [17].
Vector control interventions have a higher potential 
for success when community engagement and partici-
pation are explicitly incorporated into the control pro-
gramme [18]. Community involvement can increase local 
programme ownership, encourage greater awareness of 
health promotion, and increase uptake and sustainability 
of interventions [19, 20]. HI and LSM require a consider-
able labour input, and both interventions are essentially 
interwoven into a community via their living space and 
surrounding environment. Therefore, integrating a strong 
community engagement strategy into the implementa-
tion of these interventions could strengthen their effec-
tiveness, scalability, and sustainability.
This study aimed to inform malaria control policy 
in Malawi by evaluating the effect of community-
based HI and LSM on malaria parasite prevalence and 
transmission intensity as measured by the entomologi-
cal inoculation rate (EIR). The trial interventions, HI 
and LSM, were implemented as supplementary inter-
ventions in addition to the Malawi National Malaria 
Control Programme (NMCP) interventions, and the 
entire study site was part of an intensive community 
Conclusions: In the context of high insecticide‑treated bed net use, neither community‑based HI, LSM, nor HI + LSM 
contributed to further reductions in malaria transmission or prevalence beyond the reductions observed over two 
years across all four trial arms. This was the first trial, as far as the authors are aware, to test the potential complemen‑
tary impact of LSM and/or HI beyond levels achieved by standard interventions. The unexpectedly low EIR values 
following intervention implementation indicated a promising reduction in malaria transmission for the area, but also 
limited the usefulness of this outcome for measuring differences in malaria transmission among the trial arms.
Trial registration PACTR, PACTR201604001501493, Registered 3 March 2016, https:// pactr. samrc. ac. za/.
Keywords: Malaria, Larval source management, House improvement, Community engagement, Cluster randomised 
trial
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education and engagement programme aimed at 
increasing community participation in malaria con-
trol. The trial used a factorial design to evaluate the 
effects of HI and LSM alone or in combination with 




The study was a two-by-two factorial, cluster-rand-
omized controlled trial in communities around the 
Majete Wildlife Reserve in Chikwawa District, south-
ern Malawi (Fig.  1), an area that historically has high 
malaria transmission [21]. Malaria control in the dis-


















Fig. 1 Maps of the study site. Top left panel shows the location of the site as a yellow rectangle in southern Malawi; country borders are shown in 
red. Top right panel shows locations of the three focal areas, labelled A, B, and C, around the perimeter of the Majete Wildlife Reserve (Majete WR); 
district borders are shown in black. A, B, and C show the locations of the 65 villages in the Majete Malaria Project catchment area, with the colour of 
each village denoting the trial arm allocation as indicated in the legend; scale bar applies to A, B, and C. HI house improvement, LSM larval source 
management
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through the Chikwawa District Health Office. From 
2015 to 2018 the malaria control strategy consisted 
of provision of ITNs to pregnant women and children 
under 5  years old, mass distribution campaigns of 
ITNs, intermittent preventative therapy for pregnant 
women, and malaria case diagnosis and treatment with 
artemisinin-based combination therapy. The last mass 
distribution of ITNs in the district during the study 
period occurred in April 2016 and included  PermaNet® 
2.0 (Vestergaard Frandsen, Lausanne, Switzerland), 
 Olyset® Net (Sumitomo Chemical Company, Tokyo, 
Japan), and Royal  Sentry® (Disease Control Technolo-
gies, USA). The NMCP implemented IRS in Chikwawa 
District in 2010 and 2012 with alphacypermethrin, but 
indoor residual spraying was not done in the district 
during the study period.
The trial villages were all located within the catch-
ment area of the Majete Malaria Project, a collabo-
ration of academic institutions, non-governmental 
organizations, and the government of Malawi. Commu-
nity engagement and participation were a central focus 
of the project’s strategy to reduce malaria transmission 
and burden. The Hunger Project, a non-governmental 
organization specializing in community-based rural 
development, guided the principles followed to imple-
ment behaviour change communication (including fort-
nightly malaria workshops) and malaria vector control 
interventions through a community-based approach 
[22]. The trial was conducted in three regions, which 
were referred to as focal areas A, B and C (Fig. 1), cov-
ering a total population of about 25,000 people in 65 
villages. The trial interventions were implemented at 
the village level, meaning that the entire population of 
each village was the target population.
There was considerable involvement of the Ministry 
of Health, the NMCP, and the District Health Office in 
the activities for the trial. Sensitization meetings were 
initially held at the district, traditional authority, group-
village, and village administrative levels to inform com-
munity leaders and stakeholders about the intended trial, 
enabling the researchers to formally begin the process of 
community engagement for active community involve-
ment and participation in the trial. Community engage-
ment was an on-going process involving discussions 
between research staff, community leaders, and commu-
nity members at the focal area and village levels. Com-
munity permission to conduct the trial was obtained 
from each village headman verbally, which was consid-
ered a culturally appropriate manner for the permis-
sion [23]. Community permission covered all aspects of 
the trial, including the implementation of the proposed 
trial interventions and activities for assessment of trial 
outcomes.
Randomization
The trial interventions were implemented at the village 
level. Villages were assigned to one of four groups: (a) a 
control arm, (b) HI, (c) LSM, and (d) HI + LSM. NMCP 
interventions and community engagement were used in 
all arms. A two-stage randomization process was used 
within each focal area, which took place in June 2015 at a 
community event in each focal area.
In the first stage of the randomization, a minimal sub-
set of eligible villages was excluded from the treatment-
arm allocation to reduce the risk of contamination from 
mosquito movement between different treatment arms 
[24]. Within each focal area, six potential randomization 
design options were identified, such that the remaining 
villages included in the trial for each option would form 
clusters of villages, and those clusters would be separated 
from each other by at least 800 m to reduce the potential 
for malaria mosquito movement between clusters [25]. 
At each community event in focal areas A and C, one of 
the six options was selected by drawing lots: six opaque 
folded cards corresponding to each of the six options 
were placed in a dish, and a volunteer from the commu-
nity blindly selected one card. In focal area B, this stage 
was not necessary because the geography of the villages 
was such that excluding any of the villages would not 
have created any more clusters.
In the second stage of the randomization, the unit of 
randomization was the cluster (Figs. 1, 2). At the commu-
nity event in each focal area, the clusters were assigned 
to one of the four treatment arms by drawing lots, again 
using folded cards. All village residents and research 
staff were aware of the treatment assignments due to the 
nature of the intervention.
Procedures
Two interventions were evaluated in this trial: HI and 
LSM. Both interventions were implemented using a 
community-driven approach, based on the expertise of 
The Hunger Project. Volunteers from all 65 villages in 
the Majete Malaria Project catchment area were trained 
as voluntary “health animators” by the project, covering 
a broad range of malaria topics [22] (Additional file  1). 
Most villages had one health animator who was selected 
by village leaders and guided by The Hunger Project 
using criteria of literacy skills, leadership potential and 
level of motivation [22]. In some cases, primarily based 
on village size, The Hunger Project and village leaders 
selected a second health animator for a village, so that 
there was a total of 77 health animators.
Larval source management in this trial consisted of 
draining, filling and larviciding. Water bodies were either 
drained or filled when feasible and if the community did 
not use the water for a designated purpose. All remaining 
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water bodies were targets for larviciding with Bacillus 
thuringiensis subspecies israelensis, serotype H-14, strain 
AM65-52 (abbreviated Bti; commercial name VectoBac 
WDG, Valent Biosciences, Libertyville IL, USA). Bti has 
not been used in Malawi outside of research settings, but 
it is widely used for mosquito control globally. Health 
animators in villages assigned to LSM arms were given 
additional training on the concepts and practice of LSM. 
Communities implemented all LSM activities with lead-
ership from health animators, village-level LSM commit-
tees, and community leaders (Additional file 1).
House improvement in this trial consisted of modi-
fications to houses aimed at blocking entry by malaria 
vectors. Following discussions with communities, the 
agreed modifications consist of: closing all eaves (i.e., 
where a wall meets the overhang of the roof ) using local 
material similar to that used to construct the house (i.e., 
bricks and extra mud for most houses); closing all holes 
in the wall not used for ventilation using the same mate-
rials used for closing eaves; covering windows and other 
openings used for ventilation with aluminium screens 
that allow airflow; and modifying doors so as to fully 
cover doorways when closed. Similar to LSM, health ani-
mators in villages assigned to HI arms were given addi-
tional training on the concepts and practices of HI, and 
communities implemented all HI activities with leader-
ship from health animators, village-level HI committees 
and community leaders (Additional file 1).
Entomological indicators of malaria transmission 
were assessed by sampling for mosquitoes using Suna 
traps (Biogents AG, Regensburg, Germany), which use 
a synthetic blend of volatiles found on human skin and 
carbon dioxide to attract host-seeking Anopheles mos-
quitoes [26]. The standardized odour blend allows for 
reliable comparisons among trapping locations [27]. Suna 
traps were set at the houses of study participants for two 
Fig. 2 Trial profile showing two‑stage randomization. Stage 1, randomization of villages in each focal area (block) into clusters. Stage 2, 
randomization of clusters into the four trial arms. HI house improvement, LSM larval source management, NMCP National Malaria Control 
Programme
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consecutive nights (one indoors, one outdoors), and mos-
quitoes were collected from the traps each morning after 
a night of sampling. Information about the household 
was recorded through a standardized form, including 
the types of bed nets in the house, the use of any insec-
ticides, and the presence of livestock. All collected mos-
quitoes were preserved using a desiccant and identified 
using standard morphological and molecular techniques 
(Additional file  1). Real-time PCR was used to assess 
the presence of Plasmodium falciparum parasites in the 
heads and thoraces of female Anopheles mosquitoes after 
removing the abdomens (Additional file 1).
Epidemiological data were collected using a household 
survey adapted from the internationally standardized 
malaria indicator survey, which included a core question-
naire covering demographic and socio-economic data, 
and an additional module covering malaria control inter-
vention practices and morbidity indicators [28]. For chil-
dren aged 6–59  months and women aged 15–49  years, 
the presence of P. falciparum parasites was measured 
by rapid diagnostic test (RDT; SD BIOLINE Malaria Ag 
P.f. HRP-II, Standard Diagnostics, Yongin-si, Republic 
of Korea), and haemoglobin levels were measured using 
 HemoCue® Hb 301 (HemoCue, Ängelholm, Sweden). 
These demographic groups were chosen to align with the 
groups sampled in the national malaria indicator surveys 
in Malawi prior to and during the study.
A repeated cross-sectional survey sampling framework 
was used for both epidemiological surveys and adult 
mosquito sampling, with slight differences in the house-
hold selection procedure between the baseline (April 
2015 through April 2016) and trial periods (May 2016 
through May 2018; Additional file  1). In both cases, a 
sample of households was selected from a demographic 
database covering the study area (Additional file 1) every 
2 months for the epidemiological survey, and a subset of 
those households was randomly selected for adult mos-
quito sampling. Epidemiological surveys and adult mos-
quito sampling (for selected households) were conducted 
in these households over a 6- to 8-week period in each 
round.
Outcomes
The primary outcome was the entomological inocula-
tion rate (EIR) at the end of the trial period (January 
to May 2018). EIR was calculated as the product of the 
sporozoite rate and the number of host-seeking Anoph-
eles mosquitoes collected per house over a defined period 
of time (Additional file  1). The EIR over the entire trial 
period (May 2016 through May 2018) and the difference 
between EIR in the trial period and EIR in the baseline 
period (April 2015 through April 2016) were also assessed 
as secondary outcomes. Other secondary outcomes were 
Anopheles mosquito density (indoors and outdoors; sepa-
rately by species and pooled for all Anopheles), P. falci-
parum parasite prevalence (regardless of symptoms, and 
with symptoms) in children aged 6–59  months (with 
children aged 6–23 months also analysed as a subgroup) 
and women aged 15–49  years, and haemoglobin levels 
in the same age groups. These secondary outcomes were 
assessed in three ways: the end of the trial period; aver-
aged over the entire trial period; and as the difference 
between intervention and baseline periods.
Pre‑trial power analysis
The catchment area was limited to the 65 villages 
described above at the onset of the Majete Malaria Pro-
ject [29]. From these 65 villages, 53 villages grouped into 
18 clusters were included in the trial following the ran-
domized exclusion described above (Figs. 1, 2) [24]. For 
the pre-trial power analysis, annual EIR in the control 
arm was assumed to have a log-normal distribution with 
mean and standard deviation approximately 45 and 14, 
respectively, giving an effective range of approximately 0 
to 100. It was further assumed that a clinically effective 
intervention would be one that halved the mean EIR, i.e., 
an effect size of 0.500. The resulting power to detect a 
clinically significant main effect of HI, testing at the con-
ventional 5% level, was 0.669. The associated standard 
error of the estimated effect size was 0.286. This implied 
that a 95% confidence interval for the relative reduction 
in EIR associated with a clinically significant main effect 
would extend from 0.285 to 0.876. For the main effect of 
LSM, the corresponding figures were 0.728, 0.265 and a 
range from 0.298 to 0.840.
Cluster‑level analysis
The statistical model for the primary analysis was a 
randomized block ANOVA allowing for block effects 
plus main effects for each intervention and an interac-
tion term, using a robust version of the ANOVA F-test 
that respected the restricted randomization. Differences 
were assessed at the cluster level, and every household 
was assumed to be fully covered by the interventions in 
the trial arm to which it was allocated (i.e., intention-to-
treat). In addition to the primary outcome of EIR from 
January through May 2018, this primary analysis protocol 
was also used to assess all other outcomes (including EIR, 
mosquito density, parasite prevalence and haemoglobin 
levels) in the baseline period, the trial period, at the end 
of the intervention, and as the difference between the 
trial period minus baseline. The following distributional 
assumptions were used in the statistical models: log-nor-
mal for EIR; Poisson for mosquito density; binomial for 
parasite prevalence; and normal for haemoglobin.
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Household‑ and individual‑level analysis
Differences were also assessed among the trial arms in 
mosquito density at the household level, and in parasite 
prevalence and haemoglobin levels at the individual level, 
to allow for estimation of household-level and individual-
level covariate effects. A generalized linear mixed effects 
model was fitted to each outcome variable in relation to 
demographic, socio-economic, and environmental fac-
tors, and accounting for village and household-within-
village random effects. Distributional assumptions for 
each outcome variable were the same as those used in the 
cluster-level analysis. All models included block effects 
(focal area A, B, or C) to account for unmeasured differ-
ences among the focal areas, as well as month of collec-
tion (from 1 = April 2015 to 38 = May 2018) to account 
for unmeasured differences over time.
When describing the mean EIR, 95% confidence inter-
vals were calculated assuming a Poisson distribution to 
avoid zero-width confidence intervals produced by the 
log-normal assumption when the mean was zero.
Statistical software
R version 3.5 was used for all analyses. R packages 
included mgcv, lme4 and INLA.
Results
Out of 65 eligible villages in the trial catchment area, 12 
villages were excluded from the treatment arm alloca-
tion to reduce the risk of contamination between differ-
ent treatment arms (Figs. 1, 2). The remaining 53 villages 
were grouped into 18 clusters, which were assigned to 
the four trial arms in June 2015 (Fig. 2). The 53 villages 
comprised 4558 households and a population of 20,013 
as of February 2015.
During five rounds in the baseline period (April 2015 
through April 2016) and 12 rounds in the trial period 
(May 2016 through May 2018), 1380 and 3240 house-
holds, respectively, were selected for epidemiologi-
cal surveys; in the trial period, some households were 
selected multiple times in different rounds. 1072 and 
1844 unique household visits during baseline and trial 
periods, respectively, were included in the analysis pre-
sented here, including households that were replaced by 
the nearest neighbour when the selected household was 
absent. 42 visits (baseline period) and 118 visits (trial 
period) ended when the head of household did not con-
sent, and a further 266 visits (baseline period) and 1098 
visits (trial period) were to households without at least 
one child aged 6–59 months or woman aged 15–49 years. 
In the trial period, an additional 180 household vis-
its were excluded from the presented analysis because 
they were made in villages excluded from treatment arm 
allocation. From the included visits during the baseline 
period, 894 RDT results were obtained from children 
aged 6–59 months, and 1161 RDT results were obtained 
from women aged 15–49 years. During the trial period, 
the corresponding figures were 1370 for children aged 
6–59  months and 1935 for women aged 15–49  years 
(Additional file 1: Figure S2).
Of the 1380 and 3240 households selected for epide-
miological surveys, 1104 (80%) and 2340 (72%), respec-
tively, were selected for adult mosquito sampling. In the 
analysis presented here, 1098 indoor and 1090 outdoor 
samples from the baseline period and 2043 indoor and 
2042 outdoor samples from the trial period have been 
included (Fig. 3).
The trial design resulted in an unbalanced distribution 
of the study population among the four trial arms, with 
about 1.5 times as many households in the LSM arm as in 
each of the other three arms (Table 1). The baseline char-
acteristics of the four trial arms are also shown in Table 1.
The proportion of households owning at least one ITN 
during the baseline period was 29% (95% CI 27%, 32%), 
and the proportion of children aged 6–59 months using 
an ITN was 34% (95% CI 31%, 37%). ITN ownership and 
use rose sharply to 89% (95% CI 84%, 92%) and 95% (95% 
CI 90%, 98%), respectively, following the NMCP’s mass 
distribution in April 2016, immediately prior to the start 
of the trial. Both ownership and use of ITNs fell gradually 
over the 2-year trial period, to 43% (95% CI 37%, 49%) 
and 54% (95% CI 44%, 63%), respectively, during the final 
round of data collection in March–April 2018. ITN use 
during the trial period was similar among the four trial 
arms (Table 2).
The mean number of female Anopheles mosquitoes per 
house per night decreased over the three years of data 
collection, from 0.12 indoors and 0.18 outdoors in the 
baseline period to 0.02 indoors and 0.05 outdoors in the 
last year of the trial period (Table  3). The vast majority 
of Anopheles mosquitoes collected over three years were 
either Anopheles arabiensis (67%) or Anopheles funestus 
sensu stricto (26%) (Additional file  1: Table  S1). There 
were no differences among the treatment arms when 
assessing the entomological outcomes at the cluster level 
(Additional file 1: Table S2). At the household level, after 
accounting for other risk factors the number of A. ara-
biensis outdoors was lower in the HI + LSM arm com-
pared to the control arm (rate ratio (RR): 0.14, 95% CI 
0.02, 0.74; Table 4). However, the number of A. arabiensis 
indoors was higher in both the LSM arm (RR: 11.13, 95% 
CI 2.36, 60.3) and HI + LSM arm (RR: 7.77, 95% CI 1.68, 
39.7) compared to the control arm. There were no other 
differences among the treatment arms when assessing the 
entomological outcomes at the household level. 
The mean nightly EIR in the baseline period was 
0.010 infectious bites per person (95% CI 0.006–0.015) 
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Fig. 3 Trial profile showing entomological surveys. Number of house‑nights conducting mosquito sampling indoors and outdoors in each round, 
by trial arm. HI house improvement, LSM larval source management, NMCP National Malaria Control Programme
Page 9 of 16McCann et al. Malar J          (2021) 20:232  
(Table  3), for an estimated annual EIR of 3.50. The EIR 
fluctuated annually, with seasonal peaks typically follow-
ing the rainy season and, more broadly, declining over the 
3-year period (Fig. 4). Strikingly, over the last 11 months 
of the trial period (8 June 2017 to 10 May 2018), the EIR 
was zero across all four trial arms, and therefore the pri-
mary outcome (EIR at the end of the trial period) could 
not be statistically assessed. There were no differences 
among the trial arms at the cluster level when compar-
ing the EIR from the full trial period (p = 0.33; Addi-
tional file 1: Table S2). The mean nightly EIR was 0.001 
infectious bites per person (95% CI 0.000–0.008) in the 
control arm, 0.000 (0.000–0.004) in the HI arm, 0.009 
(0.005 to 0.015) in the LSM arm, and 0.011 (0.005–0.021) 
in the HI + LSM arm (Table 4).
The prevalence of P. falciparum infection (by positive 
malaria RDT) decreased from the baseline year to the 
first year of the trial in all three age categories meas-
ured, and remained below baseline levels in the second 
year of the trial (Table 3). A similar pattern was seen with 
the prevalence of symptomatic malaria (RDT positive 
with either fever in the last 48 h or temperature ≥ 37.5) 
Table 1 Baseline characteristics of the four trial arms
HI house improvement, LSM larval source management
a Socioeconomic categories were based on ownership of household items, using principal component analysis to determine quintiles
b Sporozoite rate combined for all Anopheles species, combined for indoor and outdoor sampling
Control HI LSM HI + LSM
Study cluster characteristics
 Clusters 5 4 5 4
 Villages 7 13 24 9
 Households 1056 1030 1520 952
 Population 4244 4568 6801 4400
Household characteristics
 Median altitude of houses, m (range) 90 (66, 510) 200 (85, 632) 190 (73, 569) 225 (144, 550)
 % households in the lowest socioeconomic  categorya
(95% CI)
16.3 (11.1, 21.6) 19.1 (14.6, 23.6) 14.5 (10.5, 18.4) 12.6 (9.0, 16.2)
 % households with ≥ 1 long‑lasting insecticidal nets
(95% CI)
35.3 (28.5, 42.1) 28.8 (23.6, 34.1) 27.3 (22.3, 32.3) 30.5 (25.5, 35.5)
Children characteristics
 Median age, months (IQR; N) 31 (20, 44; 106) 30 (19, 48; 223) 33 (21, 47; 199) 30 (18, 44; 213)
 Long‑lasting insecticidal nets use (%) in children 6–59 months 
(95% CI)
43.4 (34.0, 52.8) 34.5 (28.3, 40.8) 29.1 (22.8, 35.5) 38.0 (31.5, 44.5)
 Malaria infection prevalence (%) in children 6–59 months 
(95% CI; N)
26.4 (19.0, 35.5; 106) 26.5 (21.1, 32.6; 223) 38.7 (32.2, 45.6; 199) 44.6 (38.1, 51.3; 213)
 Mean haemoglobin level in children 6–59 months, g/dL (95% 
CI; N)
10.9 (10.6, 11.1; 106) 10.7 (10.5, 10.9; 223) 10.2 (10.0, 10.5; 199) 10.2 (10.0, 10.4; 213)
Entomological characteristics
 Mean number of Anopheles females collected indoors per 
house per night (95% CI; N)
0.13 (0.07, 0.19; 150) 0.05 (0.02, 0.08; 224) 0.21 (0.15, 0.26; 252) 0.12 (0.08, 0.16; 289)
 Mean number of Anopheles females collected outdoors per 
house per night (95% CI; N)
0.21 (0.14, 0.28; 158) 0.06 (0.03, 0.10; 217) 0.31 (0.24, 0.38; 248) 0.21 (0.15, 0.26; 286)
 % Anopheles females with P. falciparum DNA in head/thorax 
(sporozoite rate)b (95% CI; N)
5.7 (1.9, 15.4; 53) 0.0 (0.0, 12.9; 26) 7.0 (3.7, 12.8; 128) 9.6 (5.1, 17.2; 94)
Table 2 Insecticide‑treated bed net use among women and children during the trial period (May 2016–May 2018), by trial arm
Age group Control HI LSM HI + LSM
Mean (%) (95% CI) Mean (%) (95% CI) Mean (%) (95% CI) Mean (%) (95% CI)
Women 15–49 years 81.0 (76.3, 85.0) 79.0 (75.3, 82.3) 74.5 (71.3, 77.4) 82.0 (77.6, 85.7)
Children 6–59 months 85.6 (80.3, 89.7) 80.0 (75.9, 83.6) 76.9 (73.0, 80.4) 85.1 (80.1, 89.1)
Children 6–23 months 81.3 (71.3, 88.3) 80.5 (72.8, 86.4) 75.3 (68.4, 81.1) 83.8 (73.8, 90.5)
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in all three age groups. For example, in children aged 
6–23  months, the prevalence of symptomatic malaria 
declined from 12.3% (95% CI 9.1%, 16.5%) at baseline to 
1.3% (95% CI 0.4%, 3.7%) in the second year of the trial. 
There were no differences among the treatment arms 
when assessing the prevalence of malaria either with 
or without symptoms at either the cluster (Additional 
file 1: Table S2) or household level in all three age cate-
gories (Table  5). Haemoglobin levels increased over the 
three years of data collection in all three age categories 
(Table 3), but there were no differences in haemoglobin 
levels among the trial treatment arms at either the cluster 
(Additional file 1: Table S2) or household level (Table 6).
Discussion
This trial assessed the potential for community-based HI 
and/or LSM to reduce malaria parasite transmission and 
prevalence beyond the level of control afforded by high 
coverage of NMCP interventions combined with com-
munity engagement. The choice of EIR as the primary 
outcome was based on the assumption that a measurable 
EIR would be more sensitive than epidemiological out-
comes to changes effected by the vector control interven-
tions being investigated [30]. Critically, the EIR decreased 
from about 3.5 infectious bites per person per year at 
baseline to zero across all four trial arms by the last year 
of the trial. This signalled a promising and important 
reduction in malaria transmission for the area, although 
EIR values of zero prevented the pre-planned assess-
ment of differences in EIR among the trial arms. The 
secondary outcomes included vector mosquito densi-
ties, malaria prevalence with and without symptoms, and 
haemoglobin levels. Most of these outcomes provided no 
evidence that either community-based HI, LSM or the 
combination of HI and LSM had an effect at either the 
village or household level. The exceptions to this were 
in the household-level analysis: there were fewer A. ara-
biensis outdoors in the HI + LSM arm compared to the 
control; but there were also more A. arabiensis indoors 
in the LSM and HI + LSM arms compared to the control. 
The observed decline in EIR to below the level of detec-
tion over the 2-year trial period was likely due to the 
high rates of ITN use following a mass ITN distribution 
and intensive community engagement across the entire 
study site to promote the NMCP control strategy. This 
reduction in EIR was accompanied by reductions in the 
prevalence of positive RDTs and the prevalence of symp-
tomatic malaria in all three measured age groups, as well 
as an increase in haemoglobin levels. Overall, in this con-
text, there was no statistical evidence that community-
based HI and/or LSM contributed to further reductions 
in malaria parasite transmission or prevalence beyond 
the reductions provided by the mass ITN distribution, 
other NMCP interventions, and the community engage-
ment programme.
Table 3 Outcomes pooled across the entire study area, over time
RDT rapid diagnostic test, EIR entomological inoculation rate, Hb haemoglobin level
a EIR and Anopheles mosquito densities are based on nightly rates
b Self-reported fever in the last 48 h or body temperature measured over 37.5 °C
Outcomes Baseline year mean 
value observed 
(95%CI)
Trial year 1 mean 
value observed 
(95%CI)
Trial year 2 mean 
value observed 
(95%CI)
EIR (indoors + outdoors)a 0.010 (0.006, 0.015) 0.011 (0.007, 0.016) 0.001 (0.000, 0.003)
All Anopheles females  indoorsa 0.119 (0.099, 0.140) 0.095 (0.077, 0.112) 0.023 (0.015, 0.032)
A. arabiensis females  indoorsa 0.101 (0.082, 0.120) 0.049 (0.036, 0.061) 0.005 (0.001, 0.009)
A. funestus females  indoorsa 0.010 (0.004, 0.016) 0.040 (0.029, 0.052) 0.013 (0.006, 0.020)
All Anopheles females  outdoorsa 0.178 (0.153, 0.203) 0.116 (0.096, 0.135) 0.047 (0.034, 0.060)
A. arabiensis females  outdoorsa 0.158 (0.134, 0.181) 0.068 (0.053, 0.083) 0.009 (0.003, 0.014)
A. funestus females  outdoorsa 0.006 (0.002, 0.011) 0.041 (0.030, 0.053) 0.035 (0.024, 0.046)
Prevalence positive malaria RDT (%), women 15–49 years 19.2 (17.0, 21.6) 8.6 (7.1, 10.4) 15.1 (13.0, 17.4)
Prevalence positive malaria RDT (%), children 6–59 months 33.8 (30.8, 36.9) 19.3 (16.8, 22.1) 22.4 (19.4, 25.8)
Prevalence positive malaria RDT (%), children 6–23 months 28.7 (23.8, 34.0) 13.3 (9.8, 17.8) 14.7 (10.7, 19.8)
Prevalence positive malaria RDT + fever/tempb (%), women 15–49 years 5.2 (4.0, 6.6) 1.3 (0.8, 2.1) 2.5 (1.7, 3.6)
Prevalence positive malaria RDT + fever/tempb (%), children 6–59 months 14.2 (12.1, 16.6) 5.8 (4.4, 7.5) 5.2 (3.7, 7.2)
Prevalence positive malaria RDT + fever/tempb (%), children 6–23 months 12.3 (9.1, 16.5) 3.0 (1.5, 5.7) 1.3 (0.4, 3.7)
Hb, g/dL, women 15–49 years 11.87 (11.78, 11.97) 12.23 (12.15, 12.31) 12.62 (12.54, 12.71)
Hb, g/dL, children 6–59 months 10.52 (10.41, 10.62) 10.86 (10.76, 10.96) 11.14 (11.03, 11.25)
Hb, g/dL, children 6–23 months 10.17 (10.00, 10.35) 10.34 (10.17, 10.52) 10.81 (10.64, 10.98)
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One limitation of the study was that the baseline EIR 
for the study site was 10 times lower than expected based 
on previous data from the region [21], and decreased to 
zero across the study site by the end of trial, limiting the 
statistical usefulness of this outcome for measuring dif-
ferences in malaria transmission among the trial arms. 
Owing to the time required for organizing the logistical 
infrastructure associated with community implementa-
tion of the trial interventions, the pre-trial power analysis 
was conducted before baseline data collection and was, 
therefore, based on previous data rather than data from 
the baseline year. Ultimately, the trial had lower power 
to assess the primary outcome than was designed, but 
the trial design could not be altered retroactively. How-
ever, the measurement of EIR during this study captured 
an important reduction in malaria parasite transmission 
over time, and changes over the study period in asymp-
tomatic and symptomatic malaria parasite prevalence as 
well as haemoglobin levels in women and children cor-
roborated the observed EIR values. Additionally, the 
unique sampling strategy (Additional file 1) used in this 
study allowed fine-scale spatio-temporal variation to be 
captured in both entomological and epidemiological 
outcomes over three years of data collection and these 
spatio-temporal patterns to be compared in greater detail 
(Amoah et al. under review).
In settings with a very high annual EIR (above 15 
infectious bites/person/year), EIR is more sensitive than 
malaria parasite prevalence to changes in transmission 
[31, 32], and, therefore, the assumed annual EIR of 45 
infectious bites/person/year prior to starting this study 
partially guided the choice of EIR as the primary outcome 
[29]. The lower than expected baseline EIR values were 
likely due to increases in ITN ownership and use from 
2000 to 2012, with the most recent mass ITN distribu-
tion prior to the study taking place in 2012 [33]. Simi-
lar reductions in malaria vector densities and EIR have 
occurred across many areas of Africa since the wide-
spread scale up of ITNs for malaria control [34–36], and 
contemporaneous studies in the current study site found 
similarly low vector densities using a wide range of mos-
quito sampling methods [27, 37–39]. Measuring malaria 
intervention effects through entomological monitoring 
remains important for understanding the contributions 
of species-specific ecologies to variations in intervention 
impact. But more efficient methods for mosquito sam-
pling or novel indicators of exposure to malaria vector 
bites (e.g., serological markers) are needed for measuring 
the impact of complementary interventions as study sites 
move toward lower transmission intensities.
This was the first trial of LSM or HI as community-
based interventions. Previous studies on HI (and in some 
cases LSM) with highly controlled implementation have 
shown the efficacy of these interventions against malaria 
indicators [15, 17]. In the current study, a new compo-
nent was added to the interventions by structuring the 
implementation through a community-based approach, 
which could provide a feasible and sustainable path to 
scale-up of the interventions. With this emphasis on 
community implementation, intervention coverage was 
dependent on community buy-in to the Majete Malaria 
Project. Consequently, in HI- and LSM-assigned vil-














        








































































Fig. 4 Entomological inoculation rate (EIR) during each month of sampling. EIR is shown as the nightly mean across the entire study site, with error 
bars showing the 95% confidence intervals
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coverage with the assigned interventions may have been 
lower than required for community-level effectiveness.
Previous controlled studies of LSM for malaria con-
trol have shown mixed results because of variation in 
the epidemiological context, larval ecology, and imple-
mentation strategies [17]. For example, where LSM has 
reduced malaria case incidence or parasite prevalence, 
ITN coverage has been less than 50% (or not reported). 
As far as the authors are aware, this is the first study to 
test the effect of LSM in the context of high ITN coverage 
following a national mass distribution that reached nearly 
90% of households. In principle, LSM would have had an 
additional impact on malaria transmission by killing the 
outdoor biting mosquitoes that are not affected by ITNs. 
Table 5 Malaria prevalence outcomes for each of the study arms, aggregated over the 2‑year trial period
HI house improvement, LSM larval source management, RDT rapid diagnostic test
a Effect size estimates are presented as odds ratios based on individual-level generalized linear models with the control arm as the reference category
b Self-reported fever in the last 48 h or body temperature measured over 37.5 °C
Control HI LSM HI + LSM



















 ratioa (95% CI)
Prevalence positive 
malaria RDT (%), 
women 15–49 
years
10.4 (7.5, 14.3) 7.8 (5.8, 10.4) 0.75 (0.37, 1.52) 14.9 (12.5, 17.6) 0.80 (0.41, 1.55) 10.2 (7.4, 13.8) 0.89 (0.41, 1.95)
Prevalence positive 
malaria RDT (%), 
children 6–59 
months
18.1 (13.6, 23.8) 13.7 (10.7, 17.3) 1.38 (0.63, 3.03) 26.8 (23.1, 30.8) 1.80 (0.91, 3.60) 19.4 (14.9, 24.9) 1.95 (0.90, 4.31)
Prevalence positive 
malaria RDT (%), 
children 6–23 
months
13.8 (7.9, 23.0) 5.5 (2.7, 10.9) 0.51 (0.09, 2.83) 20.1 (14.8, 26.7) 2.77 (0.79, 11.94) 10.8 (5.6, 19.9) 2.08 (0.43, 10.59)
Prevalence 
positive malaria 
RDT + fever/tempb 
(%), women 15–49 
years
2.2 (1.1, 4.5) 1.9 (1.1, 3.5) 0.75 (0.13, 4.10) 1.6 (0.9, 2.7) 0.59 (0.12, 2.97) 2.0 (1.0, 4.1) 0.73 (0.12, 4.57)
Prevalence 
positive malaria 
RDT + fever/tempb 
(%), children 6–59 
months
7.4 (4.6, 11.7) 5.0 (3.3, 7.6) 0.63 (0.21, 1.84) 4.6 (3.1, 6.8) 0.76 (0.29, 2.10) 6.2 (3.8, 10.0) 0.70 (0.24, 2.05)
Prevalence 
positive malaria 
RDT + fever/tempb 
(%), children 6–23 
months
5.0 (2.0, 12.2) 1.6 (0.4, 5.5) 0.02 (0.00, 1.20) 2.3 (0.9, 5.8) 0.19 (0.00, 4.53) 1.4 (0.2, 7.3) 0.05 (0.00, 2.61)
Table 6 Haemoglobin levels for each of the study arms, aggregated over the 2‑year trial period
Hb haemoglobin level, HI house improvement, LSM larval source management
a Effect size estimates are based on individual-level generalized linear models with the control arm as the reference category
Control HI LSM HI + LSM















 sizea (95% CI)
Hb, g/dL, women 
15–49 years
12.31 (12.15, 12.47) 12.61 (12.49, 12.72) − 0.10 (− 0.42, 0.21) 12.21 (12.10, 12.31) − 0.11 (− 0.37, 0.15) 12.46 (12.31, 12.61) 0.01 (− 0.30, 0.33)
Hb, g/dL, children 
6–59 months
10.80 (10.59, 11.01) 11.29 (11.16, 11.42) 0.17 (− 0.22, 0.56) 10.68 (10.55, 10.81) − 0.02 (− 0.34, 0.31) 11.08 (10.89, 11.27) 0.28 (− 0.15, 0.71)
Hb, g/dL, children 
6–23 months
10.61 (10.26, 10.96) 10.86 (10.65, 11.07) 0.08 (− 0.44, 0.61) 10.14 (9.93, 10.35) − 0.40 (− 0.90, 0.10) 10.61 (10.28, 10.95) − 0.14 (− 0.70, 0.42)
Page 14 of 16McCann et al. Malar J          (2021) 20:232 
However, the high coverage with ITNs during most of 
the trial period apparently reduced malaria vector popu-
lations to nearly unmeasurable levels in all study arms, 
reducing the power to detect any incremental effect of 
LSM. A second potential explanation for these findings 
is that the zone of LSM implementation, which extended 
to 400  m past each LSM village border, was not large 
enough, and a sufficient number of malaria vectors from 
larval habitats outside the implementation zone entered 
the LSM villages to sustain malaria transmission levels. 
The 400  m distance was based on published records of 
mosquito dispersal distance and accounting for the rela-
tively high human population density of the trial clusters 
[25], but mosquito dispersal can also vary considerably 
based on local weather conditions, land use, and natural 
or artificial barriers. Coverage of LSM is also a critical 
component of its success. Most previous studies of LSM 
have been conducted in areas where the habitats are few, 
fixed, and findable, a description that the World Health 
Organization continues to use for the current guidelines 
on LSM [17]. In the current study, the LSM committees 
were able to map and track the larval habitats in and 
around their villages (i.e., habitats were few and findable). 
Furthermore, quarterly checks on larvicide effectiveness 
showed the expected impact of Bti spraying on mosquito 
larvae, indicating that community-based spray teams are 
capable of sufficient Bti application quality on habitats 
that they sprayed. However, spray team weekly visits to 
every habitat were not verified, and there remains a pos-
sibility that poor coverage of LSM, due to missed habi-
tats, explains the results. An analysis of LSM committee 
and community LSM practices will be reported sepa-
rately, providing better evidence for whether a decen-
tralized approach to managing LSM leads to sufficient 
coverage for the intervention.
Two previous randomized controlled trials have sug-
gested that HI can reduce malaria transmission [15, 
16]. A recent systematic review and meta-analysis of 
modern versus traditional houses, including 84 obser-
vational and six intervention studies, found that hous-
ing is likely an important risk factor for malaria [40], a 
finding that was further supported by a recent multi-
country analysis of survey data [14]. The current study 
did not find evidence for HI reducing malaria trans-
mission or prevalence. As with LSM, high coverage 
with ITNs across the study site may have reduced the 
power to detect any supplemental effect of HI. Another 
likely explanation for these findings may be imperfect 
HI coverage in villages where community buy-in to 
the project was low, or where houses completing HI 
had gaps remaining in the eaves, windows or doors 
through which mosquitoes may have entered. For HI 
to be effective for reducing malaria transmission, all 
openings for mosquito entry on a house should be com-
pletely screened or completely closed, which effectively 
reduces indoor malaria vector densities [37]. Future 
work should assess HI implementation strategies that 
better manage HI quality while still giving the commu-
nities ownership over the process. Also, future studies 
are needed to understand the effect of different house 
designs on mosquito entry and malaria transmission as 
well as the acceptability, feasibility, and sustainability 
of those designs in communities where they would be 
implemented [41].
Conclusions
This trial was conducted in the context of a mass ITN 
distribution and an intensive community engagement 
project, with high ITN use leading to markedly reduced 
malaria parasite transmission and prevalence in the 
entire study area, including in the control and interven-
tion arms. Notably, the EIR across the four trial arms 
decreased to zero over 2  years. In this setting, commu-
nity-based LSM and/or HI did not provide any further 
reduction in malaria transmission or prevalence beyond 
the level reached in the control arm. Other studies, with 
higher malaria transmission intensities and lower ITN 
use than in this study area in southern Malawi, have 
shown that LSM and HI are efficacious malaria inter-
ventions [17, 40]. In settings with very low transmission 
resulting from high ITN use and effective treatment, 
novel evaluation strategies are required to demonstrate 
the impact of LSM and HI as complementary interven-
tions, with the potential to cause further reductions in 
malaria transmission and move towards elimination of 
malaria.
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